NDRA – endra life sciences inc. (US:NASDAQ)
Stock Stats
News
ENDRA Life Sciences (NASDAQ:NDRA) had its price target lowered by analysts at Ascendiant Capital Markets from $38.00 to $30.00. They now have a "buy" rating on the stock.
ENDRA’s TAEUS® Liver Matches MRI-PDFF Performance at Key Clinical Thresholds, Positioning Device for MASLD/MASH Trial Use
ENDRA Feasibility Study Demonstrates TAEUS® Accurately Quantifies Liver Fat Fraction, a Key MASLD/MASH Biomarker
ENDRA Life Sciences Recaps Major Milestones and New Strategic Initiatives, Announces Third Quarter 2025 Financial Results
ENDRA Life Sciences Commences Staking of HYPE Digital Asset Holdings, Reinforcing Long-Term Strategy with Anchorage Digital and ARCA
Form 4 ENDRA Life Sciences Inc. For: Jan 21 Filed by: Harsh Michael
Form 4 ENDRA Life Sciences Inc. For: Jan 21 Filed by: DIGIANDOMENICO ANTHONY
Form 4 ENDRA Life Sciences Inc. For: Jan 21 Filed by: Tokman Alexander Y
Form 4 ENDRA Life Sciences Inc. For: Jan 21 Filed by: Jacroux Richard
Form 4 ENDRA Life Sciences Inc. For: Jan 21 Filed by: Basenese Lou
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.